Literature DB >> 35654601

Collaboration between Dialysis Providers.

Jeffrey Silberzweig1,2, J Ganesh Bhat3,4, Mary O Dittrich5, Raghu Durvasula6, Jeff Giullian7, Jeffrey L Hymes8, Doug Johnson9, Brigitte Schiller10,11, Richard Spech12, Leslie Spry13, Geoffrey Scott Walker14, Suzanne Watnick15,16, Jerry Yee17,18, Barry I Freedman19,20.   

Abstract

Entities:  

Keywords:  COVID-19; dialysis; end stage kidney disease; outcomes; patient-centered care

Mesh：

Year:  2022        PMID： 35654601      PMCID： PMC9342651          DOI： 10.1681/ASN.2021111475

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   14.978


× No keyword cloud information.
  10 in total

1.  Mitigating Risk of COVID-19 in Dialysis Facilities.

Authors:  Alan S Kliger; Jeffrey Silberzweig
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-20       Impact factor: 8.237

2.  Clinical Course of SARS-CoV-2 Infection in Adults with ESKD Receiving Outpatient Hemodialysis.

Authors:  Ana Cecilia Bardossy; Lauren Korhonen; Sabrina Schatzman; Paige Gable; Carolyn Herzig; Nicole E Brown; Elizabeth Beshearse; Kate Varela; Sarah Sabour; Amanda K Lyons; Rahsaan Overton; Matthew Hudson; Alfonso C Hernandez-Romieu; Jorge Alvarez; Kaylin Roman; Mark Weng; Elizabeth Soda; Priti R Patel; Crystal Grate; Lorien S Dalrymple; Rebecca L Wingard; Natalie J Thornburg; Alison S Laufer Halpin; Jennifer M Folster; Melissa Tobin-D'Angelo; Janice Lea; Ibironke Apata; L Clifford McDonald; Allison C Brown; Preeta K Kutty; Shannon Novosad
Journal:  Kidney360       Date:  2021-09-22

3.  COVID-19-Associated Mortality among Kidney Transplant Recipients and Candidates in the United States.

Authors:  Sumit Mohan; Kristen L King; S Ali Husain; Jesse D Schold
Journal:  Clin J Am Soc Nephrol       Date:  2021-09-29       Impact factor: 8.237

4.  Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2.

Authors:  Claudius Speer; Daniel Göth; Louise Benning; Mirabel Buylaert; Matthias Schaier; Julia Grenz; Christian Nusshag; Florian Kälble; Martin Kreysing; Paula Reichel; Maximilian Töllner; Asa Hidmark; Gerald Ponath; Paul Schnitzler; Martin Zeier; Caner Süsal; Christian Morath; Katrin Klein
Journal:  Clin J Am Soc Nephrol       Date:  2021-05-24       Impact factor: 10.614

5.  Initial Effects of COVID-19 on Patients with ESKD.

Authors:  Eric D Weinhandl; James B Wetmore; Yi Peng; Jiannong Liu; David T Gilbertson; Kirsten L Johansen
Journal:  J Am Soc Nephrol       Date:  2021-04-08       Impact factor: 14.978

6.  The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action.

Authors:  Anna Francis; Colin Baigent; T Alp Ikizler; Paul Cockwell; Vivekanand Jha
Journal:  Kidney Int       Date:  2021-02-12       Impact factor: 10.612

7.  COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider.

Authors:  Caroline M Hsu; Daniel E Weiner; Gideon Aweh; Dana C Miskulin; Harold J Manley; Carol Stewart; Vlad Ladik; John Hosford; Edward C Lacson; Douglas S Johnson; Eduardo Lacson
Journal:  Am J Kidney Dis       Date:  2021-01-17       Impact factor: 8.860

8.  COVID-19 infection control measures and outcomes in urban dialysis centers in predominantly African American communities.

Authors:  Ibironke W Apata; Jason Cobb; Jose Navarrete; John Burkart; Laura Plantinga; Janice P Lea
Journal:  BMC Nephrol       Date:  2021-03-06       Impact factor: 2.388

9.  COVID-19 and maintenance hemodialysis: a systematic scoping review of practice guidelines.

Authors:  Hossein Akbarialiabad; Shahin Kavousi; Aria Ghahramani; Bahar Bastani; Nasrollah Ghahramani
Journal:  BMC Nephrol       Date:  2020-11-10       Impact factor: 2.388

10.  Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.

Authors:  Shuchi Anand; Maria Montez-Rath; Jialin Han; Julie Bozeman; Russell Kerschmann; Paul Beyer; Julie Parsonnet; Glenn M Chertow
Journal:  Lancet       Date:  2020-09-25       Impact factor: 202.731
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.